17TH International
Ultmann Chicago Lymphoma Symposium

Virtual Scientific Program

Scientific Program

Presentations will be delivered virtually

Please find the agenda below.

*Agenda subject to change

Friday: August 28, 2020

Session times are in CDT

8:00 AM – 8:15 AM WELCOME AND INTRODUCTIONS
8:15 AM – 9:30 AM Mini Symposium on Follicular Lymphoma

  • Molecular Genetics of FL
    Jessica Okosun, MA, MB BChir, MRCP, FRCPath, PhD
  • Treatment of Newly Diagnosed Disease
    Brian Hill, MD, PhD
  • Treatment of Relapsed Disease and New Approvals
    Ian Flinn, MD
9:30 AM – 9:45 AM BREAK
9:45 AM – 11:00 AM Mini Symposium on CLL

  • Frontline Treatment – Monotherapy, Double, or Triplet – What to Do?
    Nitin Jain, MD
  • Biology of CLL at Progression: How Does That Inform Treatment
    Adrian Wiestner, MD, PhD
  • Richter’s Transformation
    Deborah Stephens, DO
11:00 AM – 11:15 AM BREAK
11:15 AM – 12:15 PM Chicago Hematopathology Multidisciplinary Tumor Board

  • Hematopathologists and a Clinician Review Case Vignettes and Discuss the Interplay in Diagnosis
    Girish Venkataraman, MD, Mir Alikhan, MD, Shunyou Gong, MD, PhD, Madhu Menon, MD, PhD
12:15 PM – 12:30 PM BREAK
12:30 PM – 1:30 PM Keynote Presentation: Pathogenesis and Clinical Course of Aggressive Lymphomas
Ari Melnick, MD
1:30 PM General Session Wrap Up and Adjourn

Nursing Agenda

1:45 – 2:15 PM Primer on Lymphoma
Sonali Smith, MD, FASCO – Co-Chair
2:15 – 3:00 PM Toxicity of Immunotherapy in Frontline Therapy

  • Side Effects of Immunotherapy
    Pankti Reid, MD
3:00 PM – 3:15 PM BREAK
3:15 – 4:00 PM Practical Approach to Imaging in Patients with Lymphoma
Caitlin Murphy, DNP, FNP-BC, AOCNP
4:00 PM – 4:15 PM BREAK
4:15 – 5:00 PM Diving into the Diagnosis

  • FISH and Other Laboratory Tests
  • Clinical Complications of these tests for our lymphoma patients
    Carrie Fitzpatrick, PhD and Jacky Gideon, ANP
5:00 PM Nursing Session Wrap-Up and Adjourn

Saturday: August 29, 2020

Session times are in CDT

8:00 AM – 8:15 AM

WELCOME AND INTRODUCTIONS

8:15 AM – 9:30 AM

Mini Symposium on R/R DLBCL

  • Cellular Therapy: Is the Efficacy of CAR T-cells Dependent Upon Lymphoma Subtype
    Krishna Komanduri, MD
  • Immunotherapy Options for DLBCL Beyond CAR T-cells
    Justin Kline, MD
  • Non-Immunotherapy Options for R/R DLBCL
    Jason Westin, MD, MS, FACP

9:30 AM – 9:45AM

BREAK

9:45 AM – 11:00 AM

Mini Symposium on T-Cell Lymphoma

  • Systemic therapies for CTCL
    Neha Mehta-Shah, MD
  • NewlyDiagnosed PTCL
    Barbara Pro, MD – Co-Chair
  • R/R PTCL
    PierLuigi Porcu, MD

11:00 AM – 11:15AM

BREAK

11:15 AM – 12:15 PM

Mini Symposium on MCL

  • When to Choose Intensive Induction Therapy
    Brad Kahl, MD
  • Relapsed MCL: Treatment Options and Sequencing
    Erel Joffe, MD, MSc

12:15 PM – 12:30 PM

BREAK

12:30 PM – 1:00 PM

Hodgkin Lymphoma: How Best to Incorporate Targeted Therapeutics into Frontline Hodgkin Lymphoma
Jane Winter, MD

1:00 PM – 1:30 PM

Summary and “Best of IUCLS”
Sonali Smith, MD, FASCO, Andrew Evens, DO, MSc, FACP, Barbara Pro, MD

1:30 PM

General Session Wrap-Up and Adjourn